Fool dismayed by pharma; UPS names biotech expert to board;

> David Williamson of the Motley Fool asks, "What happened?" after reviewing recent Big Pharma earnings. Story

> Logistics giant UPS has upped its commitment to the biopharma industry by naming its 12th director, Candace Kendle, former chairman and co-founder of contract researcher Kendle International. UPS release

> Visiongain projects global contract manufacturing revenues will experience nearly 9% annual growth through 2016, for a $64 billion market. Visiongain release

> If the future of drugs is biotech, then syringe-making is a good place to be. Unilife release

> Credit Mylan boss Heather Bresch for consistently pushing an agenda of foreign pharma plant inspections by the FDA. Story

> U.S. Customs and Border Protection seized a package containing more than 8,000 counterfeit erectile dysfunction pills at a DHL facility at the Cincinnati/Northern Kentucky International Airport. News

> Conduct plant security vulnerability assessments annually; create layers of security and put the most critical assets in the most inner layer. Article

> Jubilant Life Sciences in India has signed a three-year, $80 million supply agreement with an unnamed life sciences company to integrate "an in-house developed technology" with captively produced raw material. Announcement

> Ghanian drug officials say they will investigate whether drug barons are sponsoring the production of the fake antibiotics and condoms circulating in the West African country. Story

> On average, the National Health System in Spain takes 410 days to pay manufacturers for the drugs used in hospitals. Article